Company intelligence / Profile preview

MyungMoon Bio

Hwaseong-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~297
Development stage: Other

Overview

Myungmoon Pharm is a commercial Korean pharmaceutical company (KRX:017180) with over 250 marketed prescription and OTC medicines and at least two approved small‑molecule products associated with the company in Korea and abroad, while also sponsoring early‑stage clinical trials and pending programs including a TNF-α‑targeted rheumatoid arthritis candidate and a dwarfism program.[1][3]

Therapeutic areas: ImmunologyEndocrinologyCardiovascularGastroenterologyOncology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on MyungMoon Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyungMoon Bio.

Explore the full profile